Omnicell, Inc. balance sheet

At the end of fiscal 2025, Omnicell, Inc. had total assets of $1.97bn, total liabilities of $743m and shareholders' equity of $1.23bn. It held $197m in cash against $168m of debt: net cash of $28.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Omnicell, Inc.: balance sheet, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	169	176	192	62	105	126	82	54	32	67	127	486	349	330	468	369	197	292
Receivables	—	43	39	55	59	83	108	150	190	196	218	190	241	299	252	256	217	227
Inventory	—	10	18	27	31	32	47	69	96	101	108	96	120	148	110	89	101	97
Total current assets	—	265	284	181	234	283	264	315	352	397	483	829	781	882	928	815	680	735
Goodwill	—	29	29	111	111	123	148	328	338	336	337	499	739	734	736	735	738	737
Total assets	—	343	364	442	493	560	579	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121	1,975	1,999
Accounts payable	—	13	11	18	16	19	23	27	48	38	46	40	72	63	45	52	44	50
Deferred revenue (current)	—	—	—	—	—	—	54	88	79	82	91	100	112	119	122	141	172	188
Total current liabilities	—	58	61	83	92	112	125	181	205	205	237	276	876	428	368	596	477	447
Short-term debt	—	—	—	—	—	—	0	8	15	0	—	—	—	—	—	—	—	—
Long-term debt	—	—	—	—	—	—	0	246	195	135	50	467	0	567	570	166	168	168
Total debt	0	0	0	0	0	0	0	254	210	140	50	467	488	567	570	341	168	168
Total liabilities	—	78	81	134	144	170	176	503	462	402	396	857	996	1,081	1,038	878	743	707
Shareholders' equity	242	265	283	308	349	390	420	459	554	680	845	968	1,147	1,130	1,189	1,243	1,232	1,292
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	—	—	−18	−27	—	—	—	—	—	—	—	—	—	—
Net debt (negative = net cash)	−169	−176	−192	−62	−105	−126	−82	200	178	73	−77	−19	139	236	102	−28	−29	−124
Shares outstanding	—	33m	33m	34m	35m	36m	—	37m	38m	40m	42m	43m	44m	45m	46m	46m	45m	46m

US$ millions unless shown otherwise. Fiscal quarters.

Omnicell, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	252	256	252	233	246	217	250	227
Inventory	95	89	91	106	107	101	99	97
Total current assets	1,011	815	840	845	660	680	722	735
Goodwill	737	735	736	738	738	738	737	737
Total assets	2,304	2,121	2,151	2,145	1,949	1,975	2,004	1,999
Accounts payable	48	52	53	62	62	44	58	50
Deferred revenue (current)	152	141	160	154	179	172	212	188
Total current liabilities	962	596	608	594	457	477	483	447
Long-term debt	0	166	167	167	167	168	168	168
Total debt	0	166	167	167	167	168	168	168
Total liabilities	1,072	878	894	882	728	743	747	707
Shareholders' equity	1,231	1,243	1,257	1,264	1,221	1,232	1,257	1,292
Shares outstanding	46m	46m	47m	46m	45m	45m	45m	46m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: OMCL vs WAY OMCL vs TEM GDRX vs OMCL

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Omnicell, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Omnicell, Inc.